InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17) (VK496040)

Name: InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17)
Brand: abinScience
SKU: VK496040
Price: 370 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

100ug
1mg

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo	VK496040
Descripción	InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17) [DA03E17] (VK496040) is a human monoclonal antibody detecting EC:3.2.1.18 in ELISA, Neutralization. Suitable for Influenza B virus.
Reactividad de especies	Influenza B virus
Aplicaciones	ELISA, Neutralization
Especie huésped	Human
Clonalidad	Monoclonal
Isotipo	IgG1, kappa
ID de clon	DA03E17
Objetivo	EC:3.2.1.18, NA, Neuraminidase
Nivel de endotoxinas	< 1 EU/mg
Pureza	>95% as determined by SDS-PAGE.
Purificación	Protein A/G purified from cell culture supernatant.
Forma	Liquid
Buffer de almacenamiento	0.01M PBS pH 7.4. Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Fondo	Neuraminidase (NA) is a ~51 kDa protein. Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates. Cleaves off the terminal sialic acids on the glycosylated HA during virus budding to facilitate virus release. Additionally helps virus spread through the circulation by further removing sialic acids from the cell surface. These cleavages prevent self-aggregation and ensure the efficient spread of the progeny virus from cell to cell. Otherwise, infection would be limited to one round of replication.
Nota	For research use only.